Is GSK 2118436 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use GSK 2118436? Is GSK 2118436 safe for nursing mother and child? Does GSK 2118436 extracts into breast milk? Does GSK 2118436 has any long term or short term side effects on infants? Can GSK 2118436 influence milk supply or can GSK 2118436 decrease milk supply in lactating mothers?
Answer by DrLact: About GSK 2118436 usage in lactation
No information is available on the clinical use of GSK 2118436 during breastfeeding. Because GSK 2118436 is more than 99% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during GSK 2118436 therapy and for 2 weeks after the last dose.
Alternate Drugs
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Vincristine(Dangerous)
Pazopanib(Unsafe)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Nivolumab(Unsafe)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Azelaic Acid(Safe)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Letrozole(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Exemestane(Dangerous)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Erlotinib(Unsafe)
Allopurinol(Safe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)